Clara Crespillo‐Andújar

Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort

Pilar Vizcarra, Ana Moreno, María Jesús Vivancos et al. · The Lancet HIV · 2020 · 396 citations · Full text

Public Health, Infectious Diseases, Clinical Epidemiology +10

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Hitoshi Honda, Robert Fowler et al. · The Lancet Respiratory Medicine · 2021 · 248 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Zika among international travellers presenting to GeoSentinel sites, 2012–2019: implications for clinical practice

Kristina M Angelo, Rhett J. Stoney, Gaelle Brun-Cottan et al. · Journal of Travel Medicine · 2020 · 143 citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +10

Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial

María‐Jesús Pinazo, Colin Forsyth, Irene Losada et al. · The Lancet Infectious Diseases · 2024 · 56 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +5

Toxicity of nifurtimox as second-line treatment after benznidazole intolerance in patients with chronic Chagas disease: when available options fail

Clara Crespillo‐Andújar, Sandra Chamorro-Tojeiro, Francesca Norman et al. · Clinical Microbiology and Infection · 2018 · 41 citations

Medicine, Pharmacology, Pharmacotherapy +6